Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Measurement of urinary 6-beta-hydroxycortisol excretion as an in vivo parameter in the clinical assessment of the microsomal enzyme-inducing capacity of antipyrine, phenobarbitone and rifampicin.

× No keyword cloud information.

24 in total

1. Studies on the disposition of antipyrine, aminopyrine, and phenacetin using plasma, saliva, and urine.

Authors: E S Vesell; G T Passananti; P A Glenwright; B H Dvorchik
Journal: Clin Pharmacol Ther Date: 1975-09 Impact factor: 6.875

2. 6beta-Hydroxycortisol and other polar corticosteroids: measurement and significance in human urine.

Authors: A G FRANTZ; F H KATZ; J W JAILER
Journal: J Clin Endocrinol Metab Date: 1961-10 Impact factor: 5.958

3. The determination of 17,21-dihydroxy-20-ketosteroids in urine and plasma.

Authors: R H SILBER; C C PORTER
Journal: J Biol Chem Date: 1954-10 Impact factor: 5.157

4. Urinary D-glucaric acid excretion and plasma antipyrine kinetics during enzyme induction.

Authors: M Davis; C J Simmons; B Dordoni; R Williams
Journal: Br J Clin Pharmacol Date: 1974-06 Impact factor: 4.335

5. Evaluation of in vivo parameters of drug metabolizing enzyme activity in man after administration of clemastine, phenobarbital or placebo.

Authors: A G Hildebrandt; I Roots; M Speck; K Saalfrank; H Kewitz
Journal: Eur J Clin Pharmacol Date: 1975-06-13 Impact factor: 2.953

6. The effect of spironolactone on antipyrine metabolism in man.

Authors: D H Huffman; D W Shoeman; P Pentikäinen; D L Azarnoff
Journal: Pharmacology Date: 1973 Impact factor: 2.547

7. A kinetic photometric method for serum gamma-glutamyl transpeptidase.

Authors: G Szasz
Journal: Clin Chem Date: 1969-02 Impact factor: 8.327

8. Prediction of drug oxidation rates in man: lack of correlation with serum gamma-glutamyl transpeptidase and urinary excretion of D-glucaric acid and 6 beta-hydroxycortisol.

Authors: S E Smith; M D Rawlins
Journal: Eur J Clin Pharmacol Date: 1974 Impact factor: 2.953

9. The relationship between liver volume, antipyrine clearance and indocyanine green clearance before and after phenobarbitone administration in man.

Authors: C J Roberts; L Jackson; M Halliwell; R A Branch
Journal: Br J Clin Pharmacol Date: 1976-10 Impact factor: 4.335

10. Induction of hepatic microsomal enzymes after brief administration of rifampicin in man.

Authors: J P Miguet; P Mavier; C J Soussy; D Dhumeaux
Journal: Gastroenterology Date: 1977-05 Impact factor: 22.682

72 in total

Review 1. Assessment of liver metabolic function. Clinical implications.

Authors: J Brockmöller; I Roots
Journal: Clin Pharmacokinet Date: 1994-09 Impact factor: 6.447

2. The lignocaine metabolite (MEGX) liver function test and P-450 induction in humans.

Authors: C Reichel; T Skodra; A Nacke; U Spengler; T Sauerbruch
Journal: Br J Clin Pharmacol Date: 1998-12 Impact factor: 4.335

3. Identification of an inducible form of cytochrome P-450 in human liver.

Authors: P B Watkins; S A Wrighton; P Maurel; E G Schuetz; G Mendez-Picon; G A Parker; P S Guzelian
Journal: Proc Natl Acad Sci U S A Date: 1985-09 Impact factor: 11.205

4. D-glucaric acid excretion in critical care patients--comparison with 6 beta-hydroxycortisol excretion and serum gamma-glutamyltranspeptidase activity and relation to multiple drug therapy.

Authors: G Heinemeyer; I Roots; P Lestau; H R Klaiber; R Dennhardt
Journal: Br J Clin Pharmacol Date: 1986-01 Impact factor: 4.335

5. Microsomal enzyme induction in children: the influence of carbamazepine treatment on antipyrine kinetics, 6 beta-hydroxycortisol excretion and plasma gamma-glutamyltranspeptidase activity.

Authors: T A Moreland; B K Park; G W Rylance
Journal: Br J Clin Pharmacol Date: 1982-12 Impact factor: 4.335

Measurement of urinary 6-beta-hydroxycortisol excretion as an in vivo parameter in the clinical assessment of the microsomal enzyme-inducing capacity of antipyrine, phenobarbitone and rifampicin.